|
Characteristics
|
No. of patients
|
Klotho expression
|
p value
|
|---|
|
Positive (%)
|
Negative
|
|---|
|
Age (years)
|
|
<60
|
27
|
4(14.8%)
|
23
|
0.857
|
|
≥60
|
23
|
3(13.0%)
|
20
|
|
Gender
|
|
Male
|
26
|
2(7.7%)
|
24
|
0.181
|
|
Female
|
24
|
5(20.8%)
|
19
|
|
Ann Arbor stage
|
|
I or II
|
12
|
5(41.7%)
|
7
|
0.002
|
|
III or IV
|
38
|
2(5.3%)
|
36
|
|
B symptoms
|
|
Present
|
14
|
2(14.3%)
|
12
|
0.971
|
|
Absent
|
36
|
5(13.9%)
|
31
|
|
Subtype
|
|
GCB
|
15
|
2(13.3%)
|
13
|
0.929
|
|
Non-GCB
|
35
|
5(14.3%)
|
30
|
|
Serum LDH
|
|
Normal
|
35
|
5(14.3%)
|
30
|
0.929
|
|
Elevated
|
15
|
2(13.3%)
|
13
|
|
Extranodal involvement
|
|
Absent
|
28
|
4(14.3%)
|
18
|
0.45
|
|
Present
|
22
|
3(13.7%)
|
25
|
|
IPI score
|
|
0–2
|
35
|
6(17.1%)
|
29
|
0.328
|
|
3–5
|
15
|
1(6.7%)
|
14
|
-
LDH lactate dehydrogenase, IPI international prognostic index
